Remove Communication Remove Drug Development Remove Labelling
article thumbnail

What are the Top Pharma Podcasts in 2025?

Pharma Marketing Network

Table of Contents Why Pharma Podcasts Are Gaining Momentum The Best Pharma Marketing Podcasts in 2025 Top Drug Development and Biotech Podcasts Emerging Voices and Niche Pharma Shows Conclusion and FAQs Why Pharma Podcasts Are Gaining Momentum In today’s information-saturated world, audio content has carved out a unique advantage. “Eye

article thumbnail

GE HealthCare’s PET imaging agent gains Alzheimer’s label expansion

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has expanded the indications of an imaging agent developed by GE HealthCare, which will likely put it at the forefront of the Alzheimer’s diagnostics arena. Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How AI and machine learning are transforming drug discovery

Pharmaceutical Technology

Particularly beneficial in the early drug discovery phase, AI can help identify potential drug targets more effectively than traditional methods, accelerating the initial stages of drug development by quickly sifting through large volumes of data.

article thumbnail

NHC Submits Comments on CMS Draft Guidance for IPAY 2028

Putting Patients First Blog

Even well-intentioned policies can create access disparities if communication and operational support are lacking. The process by which CMS will determine that a drug qualifies for renegotiation should be more transparent. Nor are refund processes standardized or consistently communicated across payers and providers.

article thumbnail

AI in Medical Affairs: Revolutionizing Life Sciences with AI-Powered Tools

Viseven

Scientific communication : Drafting slide decks, scientific responses, medical information letters, and training content using generative models, ensuring scientific accuracy and compliance in messaging and content.

article thumbnail

Pharmacist to Clinical Strategy Leader: Brendan Doran on Building a Career in Biotech

The Nontraditional Pharmacist

And ultimately, it’s to ensure we get the data because the data are ultimately what turns into your FDA approved label and demonstrates what you need. And we work with contract research organizations to do a lot of that on our behalf, but really, we do a lot of overseeing them. And then paramount, obviously, is patient safety.

article thumbnail

FDA approves label updates for BMS’ CAR T cell therapies

Pharmaceutical Technology

June 27, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Label updates have been approved for BMS’ CAR T cell therapies, Breyanzi and Abecma, to treat multiple myeloma. The regulatory agency has also given approval to the removal of the REMS requirement from the product labels. Credit: Saiful52 / Shutterstock.